Related Experiment Video
Updated: Jun 24, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Microscopic Colitis Secondary to Leflunomide: A Case Report.
Mohamed A Ebrahim1, Eli A Zaher1, Parth Patel1
1Internal Medicine, Ascension Saint Joseph Hospital, Chicago, USA.
Microscopic colitis, a cause of chronic diarrhea, was diagnosed in a rheumatoid arthritis patient after starting leflunomide. Stopping the drug resolved symptoms, indicating leflunomide as the likely cause of this rare condition.
Area of Science:
- Gastroenterology
- Rheumatology
- Pharmacology
Background:
- Microscopic colitis (MC) presents as chronic watery diarrhea, diagnosed via histology.
- Rheumatoid arthritis (RA) patients may experience gastrointestinal side effects from medications.
Observation:
- A 63-year-old female with RA developed persistent diarrhea after initiating leflunomide.
- Colonoscopy appeared normal, but colonic biopsies confirmed microscopic colitis.
Findings:
- Discontinuation of leflunomide resulted in complete resolution of the patient's diarrhea.
- This suggests leflunomide was the causative agent for microscopic colitis in this case.
Implications:
- Leflunomide-induced microscopic colitis is a rare but potential adverse drug reaction.
- Clinicians should consider drug-induced colitis in unexplained diarrhea, especially in patients on leflunomide.
- Thorough medication review is critical for diagnosing and managing unexplained diarrhea.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

